KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
(Q21563446)
scientific article
scientific article
Language:
Current Data About
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib